Work

Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation

Year: 2018

Type: article

Source: Neuropharmacology

DOI: 10.1016/j.neuropharm.2018.07.002

Authors: Yatendra Mulpuri, Vincent N. Marty, Joseph J. Munier, Ken Mackie, Brian L. Schmidt, Herbert H. Seltzman, Igor Spigelman

Institutions: University of California, Los Angeles, Indiana University Bloomington, Indiana University, New York University, RTI International

Language: English

Topic: Cannabis and Cannabinoid Research

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Cancer Institute, National Institute of General Medical Sciences

Awards: Peripherally-restricted cannabinoids for cancer and chemotherapy-induced pain, Training in Molecular, Cellular & Integrative Physiology, Cannabinoid Modulation of Cell Function, UC BRAID Center for Accelerated Innovation, Endocannabinoid Active Sites as Therapeutic Targets

OpenAlex ID: W2839561797

FWCI: 3.87

Cites: 80

Cited by: 62

Related to: 10